Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -1.46% | 0.00% | -26.63% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.63% | 199M | |
-22.94% | 7.77B | |
+76.23% | 4.51B | |
+6.87% | 2.76B | |
-2.10% | 2.67B | |
-47.96% | 2.09B | |
-17.49% | 1.72B | |
-19.29% | 1.49B | |
+18.29% | 1.22B | |
-44.77% | 1.12B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center